Company Quick10K Filing
Guardion Health Sciences
10-Q 2021-03-31 Filed 2021-05-17
10-K 2020-12-31 Filed 2021-03-26
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-12
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-30
S-1 2019-10-25 Public Filing
10-Q 2019-09-30 Filed 2019-11-13
S-1 2019-08-07 Public Filing
S-1 2019-07-03 Public Filing
10-Q 2019-06-30 Filed 2019-08-12
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-02-14
8-K 2021-01-28
8-K 2021-01-26
8-K 2021-01-08
8-K 2020-12-28
8-K 2020-12-01
8-K 2020-11-12
8-K 2020-10-29
8-K 2020-10-01
8-K 2020-09-02
8-K 2020-08-12
8-K 2020-07-20
8-K 2020-06-12
8-K 2020-05-14
8-K 2020-04-21
8-K 2020-04-01
8-K 2020-03-30
8-K 2020-03-19
8-K 2020-03-06
8-K 2019-12-05
8-K 2019-10-28
8-K 2019-10-22
8-K 2019-09-20
8-K 2019-09-20
8-K 2019-08-13
8-K 2019-08-12
8-K 2019-07-12
8-K 2019-04-05
8-K 2019-03-15
8-K 2019-01-30
8-K 2019-01-15

Guardion Health Sciences Financials

GHSI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash634452981,2704,7353,1982,0661,1026711742,3695,555
Accounts Receivable222547357301728153622
Inventory4450108178155183412381358304319320
PP&E277277283312324419461552584589643747
Assets2626435133,8787,3705,9164,8653,8863,6813,9715,6988,955
Accounts Payable
Long-Term Debt
Liabilities6084902567565006005873994952,0831,010906
Stockholders' Equity3461542563,1226,8705,3164,2783,4873,1861,8884,6888,049
Income Statement ($'000)2016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue566063259193221294243261161
Cost of Revenue2330309379137125939771
Gross Profit33303316611413316914916490
R&D1016106128160895297832
SG&A6768681,5092,2312,2871,7011,3051,3022,8982,471
Tax00000000
Net Income-669-856-1,584-2,196-2,333-1,810-2,148-1,385-3,048-2,385
Cash Flow ($'000)2016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-446-578-1,489-1,354-1,071-864-586-1,908-1,695
Cash Investing0-6-12-145-42-91-5-54-104
Cash Financing8284364,967-38-19-9944,1564,986